Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Tandem Diabetes Care, Inc. (TNDM)

40.61   0.68 (1.7%) 03-31 16:00
Open: 40.21 Pre. Close: 39.93
High: 41.95 Low: 40.085
Volume: 852,904 Market Cap: 2,620(M)

Technical analysis

as of: 2023-03-31 4:22:38 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 52.38     One year: 61.18
Support: Support1: 38.92    Support2: 35.27
Resistance: Resistance1: 44.84    Resistance2: 52.38
Pivot: 41.18
Moving Average: MA(5): 39.99     MA(20): 41.01
MA(100): 41.21     MA(250): 54.89
MACD: MACD(12,26): -0.2     Signal(9): 0
Stochastic oscillator: %K(14,3): 38.8     %D(3): 39.7
RSI: RSI(14): 49.4
52-week: High: 123.95  Low: 33.51
Average Vol(K): 3-Month: 1,145 (K)  10-Days: 897 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ TNDM ] has closed above bottom band by 38.0%. Bollinger Bands are 51% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 42.02 - 42.22 42.22 - 42.4
Low: 39.6 - 39.83 39.83 - 40.04
Close: 40.23 - 40.61 40.61 - 40.95

Company Description

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Headline News

Fri, 31 Mar 2023
Insiders may be rethinking their US$511k Tandem Diabetes Care, Inc. (NASDAQ:TNDM) investment now that the company has lost US$116m in value - Simply Wall St

Thu, 30 Mar 2023
Why Is Masimo (MASI) Up 0.2% Since Last Earnings Report? - Nasdaq

Wed, 29 Mar 2023
UBS Initiates Coverage of Tandem Diabetes Care (TNDM) with ... - Nasdaq

Tue, 28 Mar 2023
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by ... - MarketBeat

Sun, 26 Mar 2023
Assenagon Asset Management S.A. Has $3.93 Million Holdings in ... - MarketBeat

Sat, 18 Mar 2023
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Holdings Raised by ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 64 (M)
Shares Float 64 (M)
% Held by Insiders 0.5 (%)
% Held by Institutions 100.1 (%)
Shares Short 5,210 (K)
Shares Short P.Month 5,110 (K)

Stock Financials

EPS -0.57
EPS Est Next Qtl -3.39
EPS Est This Year -17.06
EPS Est Next Year -8.56
Book Value (p.s.) 5.88
Profit Margin (%) -8.6
Operating Margin (%) -4
Return on Assets (ttm) -2.1
Return on Equity (ttm) -16.8
Qtrly Rev. Growth 13.8
Gross Profit (p.s.) 5.85
Sales Per Share 12.29
EBITDA (p.s.) -0.27
Qtrly Earnings Growth 0
Operating Cash Flow 64 (M)
Levered Free Cash Flow 13 (M)

Stock Valuations

PE Ratio -72.52
PEG Ratio -0.1
Price to Book value 6.9
Price to Sales 3.3
Price to Cash Flow 40.62

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2017-10-09
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.